Pfizer to Cut 300 Jobs as Alzheimer's, Parkinson's Research Ends - Bloomberg

Bloomberg

Pfizer to Cut 300 Jobs as Alzheimer's, Parkinson's Research Ends Bloomberg Pfizer Inc.'s decision to stop research and development into new neuroscience drugs, including its work in Alzheimer's and Parkinson's diseases, will lead to about 300 job cuts. The move to end the neuroscience-discovery program followed an internal ... Pfizer Ends Research for New Alzheimer's, Parkinson's DrugsU.S. News & World Report Pfizer is ending research for drugs to treat Alzheimer's and Parkinson'sThe Week Magazine Pfizer halts development of Alzheimer's drugsSeeking Alpha The Boston Globe -Boston Business Journal -BioPharma Dive all 10 news articles »

from Health - Google News http://ift.tt/2D7YFjR